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2404Objectives: Clostridium difficile infections (CDIs) have increased during the past 2 decades, especially among
cardiac surgical patients, who share many of the comorbidity risk factors for CDI. Our objectives were to use a
large national database to identify the regional-, hospital-, patient-, and procedure-level risk factors for CDI; and
determine mortality, resource usage, and cost of CDIs in cardiac surgery.
Methods: Using the Nationwide Inpatient Sample database, we identified 349,122 patients who had undergone
coronary artery bypass, valve, or thoracic–aortic surgery from 2004 to 2008. Of these, 2581 (0.75%) had been
diagnosed with CDI. Multivariable regression analysis and the propensity method were used for risk adjustment.
Results: Compared with the West, CDIs were more likely to occur in the Northeast (odds ratio [OR], 1.28; 95%
confidence interval [CI], 1.12-1.47) and Midwest (OR, 1.27, 95% CI, 1.11-1.46) and less likely in the South
(OR, 0.80; 95% CI, 0.70-0.90). Medium-size hospitals (OR, 0.88; 95% CI, 0.78-0.99) had a lower risk of
CDI than did large hospitals. Older age (>75 years; OR, 2.59; 95% CI, 1.93-3.49), longer preoperative length
of stay (OR, 1.51; 95% CI, 1.43-1.60), Medicare (OR, 1.21; 95% CI, 1.05-1.39) and Medicaid (OR, 1.60; 95%
CI, 1.31-1.96) coverage, and more comorbidities were associated with CDI. Among the matched pairs, patients
with CDIs had greater mortality (302 [12%] vs 187 [7.2%], P<.001), a longer median length of stay (21 vs 11
days, P< .001), and greater median hospital charges ($193,330 vs $112,245, P< .001). The cumulative
incremental cost of CDIs was an estimated $212 million annually.
Conclusions: Our results have shown that CDI is associated with increased morbidity and resource usage.
Additional work is needed to better understand the complex interplay among regional-, hospital-, and
patient-level factors. (J Thorac Cardiovasc Surg 2014;148:2404-9)Clostridium difficile infections (CDIs) are increasing at an
alarming rate within many hospitalized patient populations,
with a parallel increase in the severity of complications,
likely because of more virulent strains of the disease.1-4
Patients undergoing cardiac surgical procedures share
many of the same demographic and comorbidity risk
factors associated with an increased risk of CDI.
Although population-based studies have clearly docu-
mented the poor outcomes of hospitalized patients with
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The Journal of Thoracic and Cardiovascular Surepidemiologic data on the morbidity and mortality from
secondary development of CDIs after cardiac surgery are
lacking.
Previous studies have documented the significantly
worse outcomes of patients with CDI in the inpatient surgi-
cal setting5 and in liver6 and solid-organ7 transplantation
populations. A retrospective study of cardiac surgical pa-
tients reported that a longer duration of intensive care unit
stay was associated with CDI but not greater mortality.8
Because that report was derived solely from the results of
2 large tertiary referral centers in the South, it might not
be applicable to the nationwide cardiac surgical population
and might not provide an accurate description of patient
outcomes in other care settings.
Our objectives were to use a US-derived, nationwide,
population-based database to identify the regional-, hospi-
tal-, patient-, and procedure-level risk factors for CDIs
and determine the excess attributable mortality, resource
usage, and cost of CDIs in cardiac surgical patients.METHODS
Data
An institutional review board–exempt, 5-year period assessment of the
Nationwide Inpatient Sample (NIS) Healthcare Cost and Utilization Proj-
ect database was conducted for 2004 through 2008. The NIS is the largestgery c November 2014
Abbreviations and Acronyms
CDI ¼ Clostridium difficile infection
CI ¼ confidence interval
ICD-9-CM ¼ ‘‘International Classification of
Diseases, Ninth Revision, Clinical
Modification’’
NIS ¼ Nationwide Inpatient Sample
OR ¼ odds ratio
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Mall-payer inpatient discharge database. The patients include a 20% strati-
fied sample of all discharges occurring in a given year from approximately
1000 hospitals in 32 to 37 states (depending on the year of the study).
The database contains information on about 8 million discharges
annually. Individual entries in the database contain information on demo-
graphics, comorbidity, hospital charges, length of stay, procedures, out-
comes, and discharge. Discharge weights are provided, which allow
extraction of nation-level estimates from the unweighted database
information.
Population
The population consisted of 349,122 patients who had undergone car-
diac surgical procedures from 2004 to 2008 (this sample extrapolates to
1,709,770 cardiac surgical procedures in the entire US population). The
most common procedures performed were coronary artery bypass grafting
(n ¼ 246,174 [71%]; codes 36.10-36.17, 36.19), isolated valve repair or
replacement (n¼ 53,933 [15%]; codes 35.10-35.14, 35.20-35.28), isolated
thoracic aneurysm repair (n ¼ 4145 [1.2%]; code 38.45), or any combina-
tion of these procedures (n ¼ 44,870 [13%]). Catheterizations and pace-
maker implantations were excluded from the analysis. We examined the
demographics and clinical characteristics, primary payer, preoperative
comorbidities, surgical procedures, and treating hospital characteristics,
such as hospital bed size, teaching status, and regional location, and corre-
lated these with CDI status. The database entries containing ‘‘International
Classification of Diseases, Ninth Revision, Clinical Modification’’ (ICD-9-
CM) codes matching these procedures were extracted from the database for
patients aged 18 to 100 years. The main exposure of interest was the pres-
ence of CDI during admission and was identified by the secondary diag-
nostic codes (ICD-9-CM code 008.45). The use of ICD-9-CM codes to
identify patients with CDI has been validated in other studies, with good
accuracy demonstrated.9,10
Outcomes
Our outcomes of interest included hospital mortality, total hospital
charges, total costs, length of stay, and discharge disposition. The need
for a colectomy procedure was also determined in patients who developed
CDI. Colectomy was defined as the presence of 1 of the following ICD-9-
CM procedure codes: 45.72 to 45.76, 45.79, or 45.8.11 The categories of
disposition were routine discharge, transferred to another inpatient facility,
transfer to another type of facility, and home healthcare. Total charges
represented the amount hospitals billed for services and did not include
professional fees. Total costs were derived from the total charges using a
cost-to-charge ratio created by the Healthcare Cost and Utilization Project
in accordance with accounting reports from the Centers for Medicare and
Medicaid Services.12 Hospital costs will tend to better estimate resource
use, because hospital charges often reflect payer policies and other factors
unrelated to resource use. The cost was calculated by multiplying the total
charges by the hospital-specific cost-to-charge ratio. The costs were
adjusted for inflation and converted to 2008 dollars using the appropriate
Consumer Price Index.The Journal of Thoracic and CarCovariables
We considered the demographics, comorbidities, insurance status,
hospital characteristics, and region in which the procedures had been per-
formed. The patient-level variables included age, gender, race, and insur-
ance status. Race/ethnicity was categorized as white, black, Hispanic,
and other/missing. Certain states do not document race on discharge re-
cords; thus, race data were missing for approximately 25% of the study
population. Insurance status was categorized as Medicare, Medicaid, pri-
vate insurance, uninsured, and other according to the primary payer listed
on the discharge record. The comorbidities for risk adjustment were
derived from the secondary ICD-9-CM diagnosis codes using the Deyo
modification of the Charlson comorbidity index.13,14 A hospital was
considered a teaching hospital if it had an American Medical
Association–approved residency program, was a member of the Council
of Teaching Hospitals, or had a ratio of full-time equivalent interns and res-
idents to beds of 0.25. The hospital region was classified by the US
Census Bureau as Northeast, Midwest, South, or West. The hospital bed
size was classified as small, medium, or large, using an algorithm devel-
oped by the Healthcare Cost and Utilization Project. The surgical
procedure was categorized as coronary artery bypass grafting, isolated
valve repair or replacement, isolated aneurysm repair, or a combination
of 2 of these.
Statistical Analysis
The mean, median, and standard deviation were calculated for all
continuous outcomes, and frequency counts and percentages were used
for categorical outcomes. Appropriate statistical tests were used for the cat-
egorical (chi-square test) and continuous (Student t test) outcomes to
compare the unadjusted differences by CDI status. All data included in
the present study were unweighted data from the NIS database.
Matching and Outcomes
Propensity scores, or the conditional probability of having CDI, were
estimated for each subject using a multivariable logistic regression model
in which the presence of CDI was the dependent variable and patient demo-
graphics, payer status, comorbidities, hospital characteristics, and proce-
dure type were the independent variables.15 The purpose of the
propensity score was to balance the covariables for patients with and
without CDI to assess the outcomes without influence from known fac-
tors.16 To match those with and without CDI, we used a 1:1 greedy match-
ing algorithmwith a caliper of 0.2 times the standard deviation of the linear
propensity score.17 The balance of covariables before and after matching
was assessed by calculating the standardized differences between those
with and without CDI.18 We also performed chi-square tests for all covari-
ables before matching and used McNemar’s test in the matched sample.
Propensity matching resulted in 2850 well-matched CDI and non-CDI
patient pairs with respect to demographics, comorbidities, surgical proce-
dures, and institutional characteristics (ie, region, teaching status; Table 1
and Figure 1).
All analyses were performed using the Statistical Analysis Systems for
Unix, version 9.2 (SAS Institute, Inc, Cary, NC).RESULTS
CDI Prevalence
Of the 349,122 discharge records included in our study,
2581 patients (0.75%) had acquired CDI during their
hospital stay. The rate of CDI increased from 5.7 to 8.2
cases/1000 patients from 2004 to 2008, peaking during
2007 at 8.4 cases/1000 patients. Patients with and
without CDI differed in a number of baseline factors
(Figure 1).diovascular Surgery c Volume 148, Number 5 2405
TABLE 1. Distribution of baseline characteristics for propensity-
matched patients with and without Clostridium difficile infection
Characteristic
CDI
(n ¼ 2580)
No CDI
(n ¼ 2580) P value
Age group (y) .7
0-44 70 (2.7) 65 (2.5)
45-54 203 (7.9) 183 (7.1)
55-64 425 (16) 405 (16)
65-74 814 (32) 840 (33)
75 1068 (41) 1087 (42)
Gender .8
Male 1549 (60) 1556 (60)
Female 1031 (40) 1024 (40)
Race or ethnicity .8
White 1594 (62) 1624 (63)
Black 154 (6.0) 141 (5.5)
Hispanic 130 (5.0) 133 (5.2)
Other or missing 702 (27) 682 (26)
Primary payer .5
Medicare 1788 (70) 1829 (71)
Medicaid 148 (5.7) 121 (4.7)
Private 522 (20) 510 (20)
Uninsured 54 (2.1) 51 (2.0)
Other 68 (2.6) 69 (2.7)
Comorbidities
Myocardial infarction 912 (35) 896 (35) .6
Heart failure 1129 (44) 1158 (45) .4
Peripheral arterial disease 261 (11) 259 (10) .9
Cerebrovascular disease 262 (10) 230 (8.9) .13
COPD 698 (27) 718 (28) .5
Rheumatoid disease 32 (1.2) 29 (1.1) .7
Peptic ulcer disease 45 (1.7) 38 (1.5) .4
Mild liver disease 11 (0) 7 (0) .3
Diabetes 448 (17) 442 (17) .8
Diabetes and complications 105 (4.1) 103 (4.0) .9
Hemiplegia or paraplegia 36 (1.4) 32 (1.2) .6
Renal disease 338 (13) 340 (13) >.9
Cancer 63 (2.4) 62 (2.4) >.9
Moderate to severe liver disease 12 (0) 6 (0) .16
AIDS 9 (0) 6 (0) .4
Surgical procedure
Isolated CABG 1461 (57) 1488 (58) .4
Isolated valve repair 518 (20) 492 (19) .4
Isolated aneurysm repair 76 (2.9) 69 (2.7) .6
Combination surgery 525 (20) 531 (21) .8
Hospital characteristics
Region .8
Northeast 719 (28) 719 (28)
Midwest 626 (24) 611 (24)
South 798 (31) 829 (32)
West 437 (17) 421 (16)
Teaching status >.9
Teaching 1738 (67) 1737 (67)
Nonteaching 842 (33) 843 (33)
Hospital bed size .3
Small 171 (7) 149 (5.8)
Medium 412 (16) 392 (15)
Large 1997 (77) 2039 (79)
Data presented as n (%). CDI, Clostridium difficile infection; COPD, chronic
obstructive pulmonary disease; CABG, coronary artery bypass grafting; AIDS,
acquired immunodeficiency syndrome.
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We found a number of predictors of CDI in the cardiac
surgical setting. Regional differences were present, with a
greater incidence of CDI in the Northeast (odds ratio
[OR], 1.28; 95% confidence interval [CI], 1.12-1.47) and
Midwest (OR, 1.27; 95% CI, 1.11-1.46) than in the South
and a greater risk in teaching hospitals (OR, 1.14; 95%
CI, 1.04-1.26). Patients with Medicare and Medicaid insur-
ance had greater odds of developing CDI (OR, 1.21; 95%
CI, 1.05-1.39; and OR, 1.60; 95% CI, 1.31-1.96; respec-
tively) than patients with private insurance. Of the surgical
procedures, patients who had undergone isolated coronary
artery bypass grafting were less likely to develop CDI
(OR, 0.69; 95% CI, 0.61-0.78) than those undergoing other
procedures. Most cardiac surgical procedures were per-
formed in large (urban hospitals with 325-450 beds;
two thirds of patients were treated in teaching hospitals;
Table 2).
Patient demographics such as older age, female gender,
longer preoperative hospital length of stay, and greater co-
morbidity burden (eg, heart failure, chronic obstructive pul-
monary disease, acute myocardial infarction, and liver
disease) were associated with an increased prevalence of
CDI. Other factors that increased the risk included emer-
gency surgery and hospital transfers (Table 2).Matching and Outcomes
Patients with and without CDI had a high comorbidity
burden, which is common in those undergoing cardiac sur-
gical procedures. Unadjusted outcomes are presented in
Table 3. The propensity-adjusted outcomes for these pa-
tients are listed in Table 4. The median length of stay for
those who developed CDI was nearly double that of those
who did not (21 vs 11 days, P<.001), hospital mortality
was significantly greater (n ¼ 302 [12%] vs n ¼ 187
[7.2%], P < .001), and the total median charges
($193,330 vs $112,245, P < .001) and hospital costs
($65,809 vs $39,094, P<.001) were greater. Among the pa-
tients with CDI, 69 (2.7%) required subsequent colectomy
during the same hospital stay. Also, significant differences
were found in the discharge disposition, with the patients
with CDI more commonly transferred to other inpatient
care facilities (n ¼ 1246 [48%] vs 775 [15%], P< .001,
respectively).
For all cardiac surgical patients in the United States, the
incremental average cost annually for CDI was estimated at
$212 million according to the weighted estimate of pa-
tients with CDI (n ¼ 12,772 [0.75%]) for the 5-year period
(Table 5).DISCUSSION
We report the regional-, local-, and patient-specific vari-
ation in the risk of developing CDI after cardiac surgicalgery c November 2014
FIGURE 1. Covariance balance plot for patients with and without Clostridium difficile infections before and after propensity matching. LOS, Length of
stay; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; AIDS, acquired immunodeficiency syndrome.
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increased, the associated costs of care were greater, and
the need for more intensive services in the follow-up period
was greater. Our findings of regional and local variation in
the occurrence of CDI, with a heightened risk for proce-
dures performed in the Northeast and Midwest and in large,
urban, and/or teaching hospitals, suggest the need for more
intense examination of regional practices and an opportu-
nity for process improvement.
A recent large hospital-based study in Barcelona, Spain,
found risk factors for CDI consistent with our results. That
epidemiologic study, which examined 365 episodes of CDI,
found significant risk associated with advanced patient age
and a high comorbidity score.19 Previous studies have found
links between CDI and mortality and morbidity in scenarios
other than cardiac surgery. In a study using NIS data to
examine patients who had undergone liver transplantation
from 2004 to 2008, Ali and colleagues6 identified CDI as
an independent risk factor for mortality. Again, comorbid-
ities and advanced patient age were risk factors for CDI.The Journal of Thoracic and CarAnother NIS database study by Pant and colleagues7 in a
solid-organ transplant population reported increased mor-
tality, length of stay, and hospital charges for patients who
developed CDI.
In contrast to our investigation, a 2007 study by Crabtree
and colleagues8 found similar risk factors for CDI in cardiac
surgical patients but no increase in 30-day mortality. Simi-
larly, a study involving 151 lung transplant recipients did
not identify a significant increase in mortality or any signif-
icant risk factors for the 7 patients who had developed CDI
during their initial hospitalization.20
In addition to patient health burden, the economic burden
of CDI on cardiac surgical patients is great, with an esti-
mated cumulative incremental cost of $212 million annu-
ally. An important aspect of our findings was the large
incremental cost of CDI to patients undergoing cardiac sur-
gery. Zerey and colleagues5 analyzed all inpatient records in
the NIS from 1999 to 2003 and made a related observation,
finding a mean $77,483 increase in total hospital charges for
patients with CDI.diovascular Surgery c Volume 148, Number 5 2407
TABLE 2. Predictors of acquiring postoperative Clostridium difficile
infection
Variable Adjusted OR (95% CI)
Age group (y)
0-44 Referent
45-54 1.19 (0.88-1.62)
55-64 1.41 (1.06-1.88)
65-74 2.03 (1.51-2.72)
75 2.59 (1.93-3.49)
Female gender 1.18 (1.08-1.29)
Nontransfers 0.85 (0.76-0.94)
Elective 0.78 (0.71-0.87)
Preoperative length of stay 1.51 (1.43-1.60)
Race or ethnicity
White Referent
Black 1.16 (0.96-1.39)
Hispanic 1.11 (0.92-1.34)
Other or missing 0.98 (0.88-1.09)
Primary payer
Private Referent
Medicare 1.21 (1.05-1.39)
Medicaid 1.60 (1.31-1.96)
Uninsured 1.00 (0.73-1.38)
Other 1.33 (1.01-1.77)
Comorbidities
Myocardial infarction 1.13 (1.02-1.24)
Heart failure 1.76 (1.60-1.92)
Peripheral arterial disease 0.86 (0.73-1.01)
Cerebrovascular disease 1.15 (0.99-1.32)
Dementia 0.58 (0.14-2.34)
COPD 1.23 (1.12-1.36)
Rheumatoid disease 0.68 (0.45-1.02)
Peptic ulcer disease 1.47 (1.06-2.05)
Mild liver disease 0.79 (0.39-1.60)
Diabetes 0.64 (0.57-0.71)
Diabetes and complications 0.82 (0.66-1.02)
Hemiplegia or paraplegia 2.11 (1.40-3.19)
Renal disease 1.49 (1.30-1.71)
Cancer 1.29 (0.98-1.70)
Moderate to severe liver disease 3.47 (1.83-6.59)
AIDS 3.93 (1.90-8.11)
Surgical procedure
Isolated CABG 0.69 (0.61-0.78)
Isolated valve repair 1.00 (0.87-1.15)
Isolated aneurysm repair 2.93 (2.17-3.95)
Hospital characteristics
Region
Northeast 1.28 (1.12-1.47)
Midwest 1.27 (1.11-1.46)
South 0.80 (0.70-0.90)
West Referent
Teaching hospital 1.14 (1.04-1.26)
Hospital bed size
Small 1.12 (0.95-1.32)
Medium 0.88 (0.78, 0.99)
Large Referent
Total patients, 349,122; total cases of CDI, 2581. OR, Odds ratio; CI, confidence
interval; COPD, chronic obstructive pulmonary disease; AIDS, acquired immunode-
ficiency syndrome; CABG, coronary artery bypass grafting.
TABLE 3. Unadjusted outcomes for patients with and without
Clostridium difficile infection
Variable
CDI
(n ¼ 2581)
No CDI
(n ¼ 346,541) P value
Median length of stay (d) 21 8
Median total charges (US$) $193,255 $88,736
Median total cost (US$) $65,799 $31,125
Hospital mortality 302 (12) 11,220 (3.2) <.0001
Discharge disposition <.0001
Home healthcare 577 (22) 110,660 (32)
Inpatient facility 1246 (48) 62,794 (18)
Other transfer 306 (12) 11,532 (3.3)
Routine/home transfer 447 (17) 161,264 (47)
Data presented as n (%), unless otherwise noted. CDI, Clostridium difficile infection.
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We recognize that our study had several limitations. The
present study made use of a large administrative database
with the potential for under- or overdiagnosis and coding er-
rors. The incidence of CDI might have been underesti-
mated, because data in the NIS database is limited to a
patient’s hospital stay. CDI could certainly have been diag-
nosed after a patient’s discharge. The results of toxin assays
and other tests used to diagnose CDI are unavailable in the
NIS, and the coding does not differentiate hospital-acquired
CDI from preoperative CDI. Nonetheless, several studies
have confirmed that ICD-9-CM codes can be an acceptable
surrogate to track CDI, with a pooled estimated positive
predictive value of 87% and negative predictive value of
99.7%.21 Although Dubberke and colleagues10 have found
that the use of the CDI ICD-9-CM code without the
‘‘present on admission’’ flag cannot distinguish between
hospital-acquired from community-acquired disease states,
we believe that the rate of community-acquired CDI in the
cardiac surgery population will be very low because the
presence of CDI would likely postpone cardiac surgery in
most instances. The duration of antibiotic use is an impor-
tant risk factor for the development of CDI, but the NIS
does not provide data on antibiotic type or duration of
use. Although we were are to perform a robust riskTABLE 4. Risk-adjusted outcomes among propensity-matched pairs
Variable
CDI
(n ¼ 2580)
No CDI
(n ¼ 2580) P value
Median length of stay (d) 21 11 <.001
Median total charges (US$) $193,330 $112,245 <.001
Median total cost (US$) $65,809 $39,094 <.001
Mortality 302 (12) 187 (7.2) <.001
Disposition <.001
Home healthcare 577 (22) 836 (32)
Inpatient facility 1246 (48) 775 (15)
Other transfer 309 (12) 189 (7.3)
Routine or home transfer 446 (17) 778 (30)
Data presented as n (%), unless otherwise noted. CDI, Clostridium difficile infection.
gery c November 2014
TABLE 5. Total and average cost annually for cardiac surgical
patients with Clostridium difficile infection
Year Total cost (US$)
Median
cost (US$)
15th-85th
percentile
2004 $145,069,123 $57,861 $30,587-120,679
2005 $203,069,363 $63,660 $34,244-137,653
2006 $217,922,600 $61,398 $32,244-129,781
2007 $234,752,447 $70,147 $37,626-151,942
2008 $262,275,350 $76,875 $39,915-164,819
2004-2008 $1,063,088,883 — —
Average annual cost $212,617,777 — —
Flagg et al Perioperative Managementadjustment using the Deyo modification of the Charlson co-
morbidity index, certain key covariates such as the degree
of frailty and severity of comorbidities are not available in
the NIS. Despite these limitations, our study leveraged the
large number of patients in the NIS database to evaluate
the association of CDI with the outcomes in cardiac surgery
patients, controlling for potential confounding variables,
including demographics, comorbidities, institution, and
payer.CONCLUSIONS
Our findings suggest that location is an important factor
in the development of CDI. Variations in the prevalence
of CDI both regionally and locally suggest an opportunity
for process improvement in high-risk locations. The occur-
rence of CDI infections is also related to patient character-
istics and is associated with greater mortality and increased
resource usage in the cardiac surgical setting. Additional
work is needed to better understand the transmission of
CDI, the role of potentially modifiable risk factors, and
the key features specific to regional hospitals that appear
to increase the risk.
The authors wish to thank Tess Parry for her valuable help in
editing our report.P
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